Unknown

Dataset Information

0

Does the antidiabetic drug metformin affect embryo development and the health of brown trout (Salmo trutta f. fario)?


ABSTRACT:

Background

Due to the rising number of type 2 diabetes patients, the antidiabetic drug, metformin is currently among those pharmaceuticals with the highest consumption rates worldwide. Via sewage-treatment plants, metformin enters surface waters where it is frequently detected in low concentrations (µg/L). Since possible adverse effects of this substance in aquatic organisms have been insufficiently explored to date, the aim of this study was to investigate the impact of metformin on health and development in brown trout (Salmo trutta f. fario) and its microbiome.

Results

Brown trout embryos were exposed to 0, 1, 10, 100 and 1000 µg/L metformin over a period from 48 days post fertilisation (dpf) until 8 weeks post-yolk sac consumption at 7 °C (156 dpf) and 11 °C (143 dpf). Chemical analyses in tissues of exposed fish showed the concentration-dependent presence of metformin in the larvae. Mortality, embryonic development, body length, liver tissue integrity, stress protein levels and swimming behaviour were not influenced. However, compared to the controls, the amount of hepatic glycogen was higher in larvae exposed to metformin, especially in fish exposed to the lowest metformin concentration of 1 µg/L, which is environmentally relevant. At higher metformin concentrations, the glycogen content in the liver showed a high variability, especially for larvae exposed to 1000 µg/L metformin. Furthermore, the body weight of fish exposed to 10 and 100 µg/L metformin at 7 °C and to 1 µg/L metformin at 11 °C was decreased compared with the respective controls. The results of the microbiome analyses indicated a shift in the bacteria distribution in fish exposed to 1 and 10 µg/L metformin at 7 °C and to 100 µg/L metformin at 11 °C, leading to an increase of Proteobacteria and a reduction of Firmicutes and Actinobacteria.

Conclusions

Overall, weight reduction and the increased glycogen content belong to the described pharmaceutical effects of the drug in humans, but this study showed that they also occur in brown trout larvae. The impact of a shift in the intestinal microbiome caused by metformin on the immune system and vitality of the host organism should be the subject of further research before assessing the environmental relevance of the pharmaceutical.

SUBMITTER: Jacob S 

PROVIDER: S-EPMC6290717 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Does the antidiabetic drug metformin affect embryo development and the health of brown trout (<i>Salmo trutta</i> f. <i>fario</i>)?

Jacob Stefanie S   Dötsch Andreas A   Knoll Sarah S   Köhler Heinz-R HR   Rogall Eike E   Stoll Dominic D   Tisler Selina S   Huhn Carolin C   Schwartz Thomas T   Zwiener Christian C   Triebskorn Rita R  

Environmental sciences Europe 20181207 1


<h4>Background</h4>Due to the rising number of type 2 diabetes patients, the antidiabetic drug, metformin is currently among those pharmaceuticals with the highest consumption rates worldwide. Via sewage-treatment plants, metformin enters surface waters where it is frequently detected in low concentrations (µg/L). Since possible adverse effects of this substance in aquatic organisms have been insufficiently explored to date, the aim of this study was to investigate the impact of metformin on hea  ...[more]

Similar Datasets

| S-EPMC6626654 | biostudies-literature
| S-EPMC5401714 | biostudies-literature
| S-EPMC6410266 | biostudies-literature
| S-EPMC5980458 | biostudies-literature
| S-EPMC3313050 | biostudies-other
| S-EPMC6963635 | biostudies-literature
| S-EPMC6998173 | biostudies-literature
| S-EPMC3643939 | biostudies-literature
| S-EPMC7607733 | biostudies-literature
| S-EPMC3749212 | biostudies-literature